July 21 (Reuters) - Valmec Ltd (VMX) FY2017 EBITDA in excess of $4 million FY2017 revenues of circa $72 million, representing growth of over 40% on fy2016
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
